OnabotulinumtoxinA (Botox®): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury

OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

(2013) David Ginsberg et al.   ADVANCES IN THERAPY

1717 CONSISTENT AND PERSISTENT LONG-TERM EFFICACY AFTER REPEAT ONABOTULINUMTOXINA DETRUSOR INJECTIONS IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY

(2013) Michael Kennelly et al.   JOURNAL OF UROLOGY

OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity

(2013) M. B. Chancellor et al.   NEUROLOGY

OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity

(2013) Eric Rovner et al.   NEUROUROLOGY AND URODYNAMICS

Long-term Efficacy and Safety of OnabotulinumtoxinA in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity: An Interim Analysis

(2013) Michael Kennelly et al.   UROLOGY

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA

(2013) Karl-Erik Andersson   Therapeutics and Clinical Risk Management

Differential Effects of Botulinum Neurotoxin A on Bladder Contractile Responses to Activation of Efferent Nerves, Smooth Muscles and Afferent Nerves in Rats

(2012) Ryosuke Takahashi et al.   JOURNAL OF UROLOGY

Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

(2012) David Ginsberg et al.   JOURNAL OF UROLOGY

Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

(2012) David Sussman et al.   NEUROUROLOGY AND URODYNAMICS

Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity

(2012) Antonella Giannantoni et al.   PHARMACOLOGICAL RESEARCH

The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review

(2012) A. Tubaro et al.   Current Urology Reports

Effects of intravesical onabotulinumtoxinA on bladder dysfunction and autonomic dysreflexia after spinal cord injury: role of nerve growth factor

(2011) Mohamed S. Elkelini et al.   BJU INTERNATIONAL

Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity

(2011) A. Conte et al.   EUROPEAN JOURNAL OF NEUROLOGY

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

(2011) Francisco Cruz et al.   EUROPEAN UROLOGY

Long-Term Effect on Quality of Life of Repeat Detrusor Injections of Botulinum Neurotoxin-A for Detrusor Overactivity in Patients With Multiple Sclerosis

(2011) Shahid Khan et al.   JOURNAL OF UROLOGY

Efficacy of Botulinum Toxin A Injection for Neurogenic Detrusor Overactivity and Urinary Incontinence: A Randomized, Double-Blind Trial

(2011) Sender Herschorn et al.   JOURNAL OF UROLOGY

Effect of repeated detrusor onabotulinumtoxina injections on bladder and renal function in patients with chronic spinal cord injuries

(2011) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: a literature overview

(2011) G del Popolo et al.   SPINAL CORD

Neurogenic Detrusor Overactivity in Patients With Spinal Cord Injury: Evaluation and Management

(2011) Arun Sahai et al.   Current Urology Reports

Bladder symptoms in multiple sclerosis: a review of pathophysiology and management

(2010) Richard Nicholas et al.   Expert Opinion On Drug Safety

Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications

(2010) Markus Naumann et al.   MOVEMENT DISORDERS

Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity

(2010) Christopher Dowson et al.   Nature Reviews Urology

Neural control of the bladder: Recent advances and neurologic implications

(2010) E. E. Benarroch   NEUROLOGY

A UK consensus on the management of the bladder in multiple sclerosis

(2009) C J Fowler et al.   POSTGRADUATE MEDICAL JOURNAL

Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX®) therapy in Germany

(2009) Björn Wefer et al.   WORLD JOURNAL OF UROLOGY

Use of Botulinum Toxin A in Adult Neurological Disorders

(2008) Wilhelm J Schulte-Mattler   CNS DRUGS

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

(2008) Hsin-Tzu Liu et al.   EUROPEAN UROLOGY

Six-Year Follow-Up of Botulinum Toxin A Intradetrusorial Injections in Patients with Refractory Neurogenic Detrusor Overactivity: Clinical and Urodynamic Results

(2008) Antonella Giannantoni et al.   EUROPEAN UROLOGY

Botulinum Toxin A Detrusor Injections in Patients with Neurogenic Detrusor Overactivity Significantly Decrease the Incidence of Symptomatic Urinary Tract Infections

(2007) Xavier Gamé et al.   EUROPEAN UROLOGY